Market report
Dermatological drug tenders in Czechia — market report, October 2025
Dermatological drug tenders in Czechia in October 2025: 7,175 tenders published (-1% month on month, +2% year on year), estimated at €177,962,831 in total, and 7,189 contracts awarded (-1% month on month, +3% year on year), worth €103,825,069 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,064), Krajská zdravotní, a.s. (824) and Fakultní nemocnice Bulovka (655); most contracts won: ROCHE s.r.o. (193), ViaPharma s.r.o. (182) and Takeda Pharmaceuticals Czech Republic s.r.o. (113). On average 1.4 bids per contract; 66% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 7,175
- Contracts awarded
- 7,189
- Contract value awarded
- €103,825,069
- Bids per contract
- 1.4
The highlighted bar is October 2025. Hover a bar for its figure; the table below has every value.
| Figure | October 2025 | September 2025 | Change | October 2024 | Change |
|---|---|---|---|---|---|
| Tenders published | 7,175 | 7,228 | -1% | 7,005 | +2% |
| Estimated value | €177,962,831 | €292,962 | +60,646% | €4,995,046 | +3,463% |
| Buyers | 36 | 31 | +16% | 33 | +9% |
| Contracts awarded | 7,189 | 7,251 | -1% | 7,008 | +3% |
| Contract value (awarded) | €103,825,069 | €12,678,450 | +719% | €6,380,904 | +1,527% |
| Winners | 287 | 290 | -1% | 282 | +2% |
| Bids per contract | 1.4 | 1.7 | — | 1.0 | — |
| Single-bid contracts | 66% | 60% | — | 100% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 193 |
| 2 | ViaPharma s.r.o. | 182 |
| 3 | Takeda Pharmaceuticals Czech Republic s.r.o. | 113 |
| 4 | Gilead Sciences s.r.o. | 108 |
| 5 | Janssen-Cilag s.r.o. | 107 |
| 6 | Avenier a.s. | 105 |
| 7 | AbbVie s.r.o. | 101 |
| 8 | Amgen s.r.o. | 98 |
| 9 | Merck Sharp & Dohme s.r.o. | 74 |
| 10 | BAYER s.r.o. | 71 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in October 2025?
- 7,175 (by 36 buyers); for comparison, September 2025: 7,228, October 2024: 7,005.
- Who won the most dermatological drug tenders in Czechia in October 2025?
- By number of contracts: ROCHE s.r.o. (193), ViaPharma s.r.o. (182), Takeda Pharmaceuticals Czech Republic s.r.o. (113), Gilead Sciences s.r.o. (108) and Janssen-Cilag s.r.o. (107); 287 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in October 2025?
- Krajská nemocnice T. Bati, a. s. (2,064), Krajská zdravotní, a.s. (824), Fakultní nemocnice Bulovka (655), Fakultní nemocnice Brno (472) and Nemocnice České Budějovice, a.s. (363).
- How competitive were dermatological drug tenders in Czechia in October 2025?
- On average 1.4 bids per contract (29 contracts with a known number of bids); 66% of contracts had a single bid.
- What were the contracts worth in October 2025?
- €103,825,069 (awarded value, 7,189 contracts); median about €650,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.